Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | BMS-936561 |
Synonyms | |
Therapy Description |
BMS-936561 (MDX-1203) is a human monoclonal anti-CD70 antibody in conjugation with a prodrug MED-A, which delivers cytotoxic effect to CD70 overexpressing cells (PMID: 25869904, PMID: 26576779). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BMS-936561 | MDX-1203|MDX 1203 | BMS-936561 (MDX-1203) is a human monoclonal anti-CD70 antibody in conjugation with a prodrug MED-A, which delivers cytotoxic effect to CD70 overexpressing cells (PMID: 25869904, PMID: 26576779). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|